GNG5 and Alzheimer disease: While, in this study, our data demonstrated that the reduction of GNG5 in neuron-derived EVs in AD patients (Fig. S16E) is consistent with the reduction of GNG5 observed in total serum-derived EVs in AD (Fig. 8H).